Stryker received a higher than expected number of femoral head/hip stem dissociation complaints for certain sizes of the LFIT V40 Femoral Heads.
Hospitals and surgeons are required to inform product users of the notification and forward the notice to everyone who needs to be aware in their organization. Providers and Stryker branches are not required to return the product as part of the notification.
More articles on devices and implants:
Safe Orthopaedics acquires Qspine’s sales force: 5 insights
Medicrea earns world’s 1st FDA approval for patient-specific cages: 5 things to know
Looking to enter the spine market? See the Xoran, Fiagon partnership
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
